Discover 658 paid clinical trials in Milwaukee, Wisconsin. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 658
Active & Responsive
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
for
Metastatic Head and Neck Squamous Cell Carcinoma,
Location: Milwaukee WI, Chicago IL, Madison WI, Iowa City IA,
Sponsor: Bicara Therapeutics
Sex: All
Age: 18+
Code: NCT06788990
Phase 2, Phase 3, Recruiting
Active & Responsive
Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
for
Ampulla of Vater Carcinoma, Appendix Carcinoma,
Location: Milwaukee WI, Wauwatosa WI, Franklin WI, Brookfield WI,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18+
Code: NCT07283939
Recruiting
Active & Responsive
Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
for
Lung Cancer Diagnosis
Location: Milwaukee WI, Deerfield IL, Chicago IL, Springfield IL,
Sponsor: Freenome Holdings Inc.
Sex: All
Age: 50+
Code: NCT06122077
Recruiting
Active & Responsive
Neural Mechanisms of Response Inhibition Training for OCRD
Location: Milwaukee WI, Oakbrook Terrace IL, Chicago IL,
Sponsor: Abbott Medical Devices
Sex: All
Age: 18+
Code: NCT06526195
Recruiting
Active & Responsive
BIOTRONIK Investigation of the LivIQ Leadless Pacemaker System
for
Leadless Pacemaker, Bradycardia, AV Block,
Location: Milwaukee WI, Ann Arbor MI, Ypsilanti MI, Rochester MN,
Sponsor: Biotronik, Inc.
Sex: All
Age: 18+
Code: NCT07118358
Recruiting
Active & Responsive
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
for
Percutaneous Coronary Intervention,
Location: Milwaukee WI, Park Ridge IL, Rockford IL, Chicago IL,
Sponsor: Duke University
Sex: All
Age: 18+
Code: NCT06909565
Phase 4, Recruiting
Active & Responsive
Validation of Early Prognostic Data for Recovery Outcome After Stroke for Future, Higher Yield Trials
for
Stroke, Stroke, Acute, Stroke, Ischemic
Location: Milwaukee WI, Park Ridge IL, Madison WI,
Sponsor: Yale University
Sex: All
Age: 18+
Code: NCT05338697
Recruiting
Active & Responsive
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
for
Heart Failure With Preserved Ejection Fraction,
Location: Milwaukee WI, Hazel Crest IL, Munster IN,
Sponsor: Amgen
Sex: All
Age: 18 - 70+
Code: NCT07037459
Phase 3, Recruiting
Active & Responsive
Comparing the Safety and Efficacy of ASI-02 to Agitated Saline for Suspected Right-to-left Shunt
for
Right-To-Left Shunt
Location: Milwaukee WI, Chicago IL, Rochester MN, Saint Cloud MN,
Sponsor: Agitated Solutions, Inc.
Sex: All
Age: 18+
Code: NCT06938347
Phase 3, Recruiting
Active & Responsive
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
for
Irritable Bowel Syndrome
Location: Milwaukee WI, Waukesha WI, Rockford IL, Paw Paw MI,
Sponsor: Dynogen Pharmaceuticals
Sex: Female
Age: 18 - 65
Code: NCT00547469
Phase 2, Phase 3, Recruiting
Active & Responsive
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
Location: Milwaukee WI, Sheboygan WI, Highland Park IL,
Sponsor: National Cancer Institute (NCI)
Sex: Female
Age: 18+
Code: NCT07198074
Phase 3, Recruiting
Active & Responsive
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
for
Recurrent Head and Neck Squamous Cell Carcinoma,
Location: Milwaukee WI, Oak Creek WI, Menomonee Falls WI,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18 - 70+
Code: NCT04671667
Phase 2, Recruiting
Active & Responsive
A Study of Lebrikizumab (LY3650150) in Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal Corticosteroids (CONTRAST-NP)
for
Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
Location: Milwaukee WI, Chicago IL, Columbus OH, Ontario,
Sponsor: Eli Lilly and Company
Sex: All
Age: 12+
Code: NCT06338995
Phase 3, Recruiting
Active & Responsive
Blood Flow Restriction Training for People With Disabilities
for
Weakness, Muscle
Location: Milwaukee WI
Sponsor: Medical College of Wisconsin
Sex: All
Age: 18+
Code: NCT06441422
Recruiting
Active & Responsive
Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study
for
Migraine
Location: Milwaukee WI, Marshfield WI, Rochester MN, St Louis MO,